Showing results (101-110 of 259) with videos related to
Sort By:
Pageof 26
Journal of Alzheimer'S Disease : JAD|July 24, 2009
Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated formHans-Wolfgang Klafki, Piotr Lewczuk, Heike Kamrowski-Kruck, et al.Journal of Alzheimer'S Disease : JAD|August 17, 2013
APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's diseaseKatrin Morgen, Lutz Frölich, Heike Tost, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2014
Genetic interaction of PICALM and APOE is associated with brain atrophy and cognitive impairment in Alzheimer's diseaseKatrin Morgen, Alfredo Ramirez, Lutz Frölich, et al.Journal of Alzheimer'S Disease : JAD|October 21, 2015
The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive ImpairmentAlexander Koppara, Steffen Wolfsgruber, Luca Kleineidam, et al.Alzheimer'S Research & Therapy|October 12, 2017
Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementiaLutz Frölich, Oliver Peters, Piotr Lewczuk, et al.Alzheimer'S Research & Therapy|May 19, 2015
Apolipoprotein E-dependent load of white matter hyperintensities in Alzheimer's disease: a voxel-based lesion mapping studyKatrin Morgen, Michael Schneider, Lutz Frölich, et al.Journal of Neurology|June 23, 2019
Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imagingKatharina Brueggen, Martin Dyrba, Arturo Cardenas-Blanco, et al.Neurology|February 27, 2015
Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCISteffen Wolfsgruber, Frank Jessen, Alexander Koppara, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersHanna Boscheck, Maxie Liebscher, Ylenia D'Elia, et al.JAMA Network Open|May 29, 2020
Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical TrialFranziska Maier, Annika Spottke, Jan-Philipp Bach, et al.Pageof 26